Inositol 1,4,5-trisphosphate (IP 3 ), a second messenger formed in response to stimulation of cell surface receptors, binds to and activates IP 3 receptors (IP 3 Rs, internal calcium release channels) to liberate calcium from intracellular stores. Phosphorylated IRBIT (IP 3 R-binding protein released with inositol 1,4,5-trisphosphate) binds to the IP 3 -binding region of the IP 3 R, from which it is displaced by IP 3 . Ando et al. , who initially identified IRBIT, used an in vitro binding assay to show that IRBIT displaced IP 3 from a fusion protein containing the IP 3 R lacking its channel domain. Scatchard analysis indicated that IRBIT acted as a competitive inhibitor that decreased the affinity of the IP 3 R for IP 3 , and mutational analysis indicated that most of the amino acid residues necessary for IP 3 binding to the IP 3 R were also involved in IRBIT binding. Both IRBIT that had been exposed to alkaline phosphatase and a mutant form (S68A, in which serine 68 was substituted with alanine) that showed decreased phosphorylation and less efficient binding to the IP 3 R than wild-type IRBIT failed to suppress IP 3 binding to the IP 3 R. IRBIT also inhibited IP 3 binding and IP 3 -dependent calcium release in cerebellar microsomes. Calcium imaging of HeLa cells in which IRBIT was depleted with siRNA revealed enhanced release of calcium compared with wild-type cells in response to stimulation with an IP 3 -generating agonist. Overexpression of S68A (which bound to endogenous IRBIT, forming a heteromultimer with weaker affinity for the IP 3 R than that of the wild-type homomultimer) also enhanced IP 3 -dependent release. Thus, the authors propose that IRBIT acts as a "pseudoligand" regulated by phosphorylation that inhibits IP 3 binding and thereby calcium release. In a second paper, another group from the Mikoshiba lab proposes a second function of IRBIT based on the idea that when IP 3 binds to IP 3 Rs, displaced IRBIT might serve to carry a signal to other partners. Shirakabe et al. therefore searched for proteins that interacted with IRBIT in extracts of mouse cerebellum. A prominent interacting protein from membrane fractions was identified as NBC1, the Na + /HCO 3 – cotransporter that shuttles HCO 3 – and Na + ions across the plasma membrane. Reciprocal immunoprecipitation experiments verified that the endogenous proteins interact. Like its binding to the IP 3 R, binding of IRBIT to NBC1 was dependent on phosphorylation of IRBIT. The functional consequence of the interaction was tested in a Xenopus oocyte system. Electrophysiological measurements showed that expression of IRBIT along with NBC1 was necessary to allow full activity of the transporter. IRBIT interacted only with the NBC1 splicing variant called pNBC1, which is present in the pancreas, where it is thought to promote HCO 3 – transport in pancreatic duct cells. Thus, the authors propose that, at least in the pancreas, physiological concentrations of IP 3 , which cause dissociation of IRBIT from IP 3 Rs, could not only promote release of calcium through the IP 3 R channel but also mobilize an IRBIT-mediated signal that modulates acid-base balance. H. Ando, A. Mizutani, H. Kiefer, D. Tsuzurugi, T. Michikawa, K. Mikoshiba, IRBIT suppresses IP 3 receptor activity by competing with IP 3 for the common binding site on the IP 3 receptor. Mol. Cell 22 , 795-806 (2006). [Online Journal] K. Shirakabe, G. Priori, H. Yamada, H. Ando, S. Horita, T. Fujita, I. Fujimoto, A. Mizutani, G. Seki, K. Mikoshiba, IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na + /HCO 3 – cotransporter 1 (pNBC1). Proc. Natl. Acad. Sci. U.S.A. 103 , 9542-9547 (2006). [Abstract] [Full Text]
Read full abstract